KOL SELECT Trademark

Trademark Overview


On Tuesday, February 28, 2017, a trademark application was filed for KOL SELECT with the United States Patent and Trademark Office. The USPTO has given the KOL SELECT trademark a serial number of 87353152. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 6, 2017. This trademark is owned by Coalesce Medcom, LLC. The KOL SELECT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing a website featuring non-downloadable software for the pharmaceutical and biotech industries, namely, software to assist them when selecting Key Opinion Leaders or KOLs (KOL is a term used in this industry to refer to more influential healthcare providers) as a consultant, to participate at advisory meetings, to speak on their behalf, or to provide medical writing support. Pharmaceutical and biotech industries have no current methodology to select KOLs to support their communication offerings beyond selecting them based on hope that the opinion leader will perform to their standards. This software utilizes a 250+ point assessment to more adequately inform the pharmaceutical and biotech industry of the opinion leaders specific experiences with these communication offerings, research interests, and knowledge of the disease state to better inform KOL selection for these activities
kol select

General Information


Serial Number87353152
Word MarkKOL SELECT
Filing DateTuesday, February 28, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 6, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website featuring non-downloadable software for the pharmaceutical and biotech industries, namely, software to assist them when selecting Key Opinion Leaders or KOLs (KOL is a term used in this industry to refer to more influential healthcare providers) as a consultant, to participate at advisory meetings, to speak on their behalf, or to provide medical writing support. Pharmaceutical and biotech industries have no current methodology to select KOLs to support their communication offerings beyond selecting them based on hope that the opinion leader will perform to their standards. This software utilizes a 250+ point assessment to more adequately inform the pharmaceutical and biotech industry of the opinion leaders specific experiences with these communication offerings, research interests, and knowledge of the disease state to better inform KOL selection for these activities

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCoalesce Medcom, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSaratoga Springs, NY 12866

Trademark Events


Event DateEvent Description
Monday, November 6, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, November 6, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 10, 2017NON-FINAL ACTION E-MAILED
Monday, April 10, 2017NON-FINAL ACTION WRITTEN
Tuesday, April 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 3, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 3, 2017NON-FINAL ACTION E-MAILED
Monday, April 3, 2017NON-FINAL ACTION WRITTEN
Monday, March 27, 2017ASSIGNED TO EXAMINER
Tuesday, March 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM